Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $804275.0.

  • Mangoceuticals' Total Current Liabilities fell 4219.6% to $804275.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $804275.0, marking a year-over-year decrease of 4219.6%. This contributed to the annual value of $1.4 million for FY2024, which is 57532.52% up from last year.
  • Per Mangoceuticals' latest filing, its Total Current Liabilities stood at $804275.0 for Q3 2025, which was down 4219.6% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Total Current Liabilities ranged from a high of $1.6 million in Q2 2025 and a low of $159176.0 during Q3 2023
  • Moreover, its 3-year median value for Total Current Liabilities was $1.3 million (2024), whereas its average is $988246.4.
  • In the last 5 years, Mangoceuticals' Total Current Liabilities skyrocketed by 77411.54% in 2024 and then tumbled by 4219.6% in 2025.
  • Mangoceuticals' Total Current Liabilities (Quarter) stood at $211078.0 in 2023, then soared by 575.33% to $1.4 million in 2024, then crashed by 43.58% to $804275.0 in 2025.
  • Its Total Current Liabilities stands at $804275.0 for Q3 2025, versus $1.6 million for Q2 2025 and $1.5 million for Q1 2025.